Suggested Use

1 to 3 tablets each day as a dietary supplement or as otherwise directed by a health care professional.

Nutrition Info

Each tablet supplies:
Biologically Active Vegetable Extract 200 mg
Vitamin C (ascorbic acid) 120 mg

Description

Used as a chelator for heavy/metal toxicity and circulation problems. Biologically active vegetable extract contains naturally occurring chlorophyll, galactoglycerides, chlorophyll (a & b), phospholipids, carotenoids, sulfolipids, plasto quinones (a, b & c) menadione, cytochrome b6 & f, platocyanine, ferridoxin, naturally occurring trace minerals.

Porphyra-Zyme binds heavy metals

In 1980, Biotics Research Corporation began investigating the use and production of Spirulina plankton. A leading expert from the University of Texas provided insight into methods of production, as well as Spirulina cultures that were the starting culture for research and production.

Production was halted when scientists at Biotics isolated what they considered the “active” principal of Spirulina - the porphyrin ring of chlorophyll. While many claims for the nutritional value of Spirulina have been made, the consensus was the most significant value in Spirulina was chlorophyll. However, the chlorophyll content in Spirulina is low (typically less than 1%).

Porphyrins have the ability to bind divalent metal ions due to the nitrogen atoms of the tetrapyrrole nucleus. The central ion in chlorophyll is magnesium, which is freed from chlorophyll under acidic conditions permitting other metals to bind in its place. Toxic metals, such as mercury lead and arsenic, are complexed first. Then excess amounts of other divalent metals, such as calcium, can be complexed by porphyrins.

Porphyra-ZymeTM - A concentrated Porphyrin product

Unlike traditional chlorophyll products, Porphyra-Zyme is a concentrated porphyrin supplement. By increasing the porphyrin content, the heavy metal binding capability is also increased, providing clinicians with a natural, effective “chelating” tool.

Investigational Data on Porphyra-zyme.

Scientists at Biotics Research Corporation studied the ability of Porphyra-Zyme to bind heavy metals in-vitro.

Porphyra-Zyme was dialyzed against aqueous solutions of heavy metal ions. Afterward, the concentration of heavy metal ion remaining in the dialysis medium was determined. As can be seen by the Investigational Data chart, Porphyra-Zyme proved to be very effective in binding heavy metals.

Using dialysis, the following exchange range for toxic metals was established:

Measurements were made using atomic absorption techniques (flame, furnace and hydride methods), using a Perkin-Elmer 603 spectrophotometer.

Product Information

Tablets per bottle: 90 tablets and 270 tablets

Product adjuncts: Multi-Mins™, Multi-Mins™ Iron/Copper Free

Initial Concentration After Dialysis Amount Percent against a solution complexed of Porphyra-Zyme

Lead 20 ppm 4.8 ppm 15.2 ppm 76%

Mercury 10 ppm 0.8 ppm 9.2 ppm 95%

Cobalt 30 ppm 3.4 ppm 26.6 ppm 88%

Cadmium 15 ppm 3.6 ppm 11.4 ppm 76%

Arsenic 10 ppm 1.4 ppm 8.6 ppm 86%

Aluminum 20 ppm 7.0 ppm 13.0 ppm 65%

Nickel 10 ppm 3.3 ppm 6.7 ppm 67%

THE STATEMENTS MADE HEREIN HAVE NOT BEEN EVALUATED BY THE U.S. FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE.
Biotics Research Corporation